Renyi Su

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University · ORCID：0000-0001-9577-7012

发表论文 42 篇 · 总被引 393 次 · h-index 10

代表论文

Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21‐Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis (2024 · Advanced Science · 被引 31)
Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma (2024 · Cancer Biology and Medicine · 被引 13)
Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression (2023 · British Journal of Cancer · 被引 13)
Insulin-induced gene 2 protects against hepatic ischemia–reperfusion injury via metabolic remodeling (2023 · Journal of Translational Medicine · 被引 9)
Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis (2024 · Journal of Advanced Research · 被引 8)
ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1 (2023 · Cell Communication and Signaling · 被引 7)